Tepotinib 225 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 225 mg
Reference Brands: Tepmetko (USA/EU)
Category: Oncology Cancer Care
Tepotinib is a Oncology Cancer Care product available as Tablets in strengths 225 mg. It corresponds to the reference brand Tepmetko (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Tepotinib is an oral anticancer medication sold under the brand name Tepmetko, used for the treatment of non-small cell lung cancer (NSCLC) in adults. It is specifically indicated for patients with metastatic NSCLC whose tumors harbor a mutation that leads to MET exon 14 skipping, a genetic alteration that drives cancer cell growth and survival.
Tepotinib works as a selective inhibitor of the MET receptor tyrosine kinase. By blocking MET signaling, it interferes with pathways that promote tumor cell proliferation, survival, and metastasis. This targeted mechanism allows for precision therapy in patients whose cancers are driven by MET exon 14 alterations. Tepotinib provides a valuable treatment option for adults with this specific form of NSCLC, offering an alternative for patients who may not respond to conventional chemotherapy.
Tepotinib — third party manufacturing & bulk supply
Tepotinib 225 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Tepotinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Tepotinib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Tepotinib is used to treat non-small cell lung cancer (NSCLC) with MET exon 14 skipping mutations by inhibiting MET receptor signaling and slowing tumor progression.
Tepotinib mesylate is a synthetic small-molecule MET kinase inhibitor that specifically targets MET-driven cancer cell growth pathways.
The trade name of tepotinib is Tepmetko.
Tepotinib (Tepmetko) is developed and marketed by Merck KGaA (EMD Serono in the USA).
The generic name is tepotinib mesylate.
The brand name is Tepmetko.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
